Looking for clues for dangerous fatty liver disease

"When you combine the fact that the natural history of the disease is unclear; it's difficulty to diagnose, treat and stage it; and there's no FDA-approved medicine, it becomes a huge issue." - Dr. Jaideep Behari, associate professor of medicine at the University of Pittsburgh and director of Fatty Liver Clinic.

Click on the headline to read the article on fatty liver disease and nonalcoholic steatohepatitis (NASH).

Story by Medical Xpress - Looking for clues for dangerous fatty liver disease